126 Relationship Between Complement Factors and CC Chemokines and the Pharmacokinetics (PK) and Pharmacodynamics (PD) of PEGylated Liposomal Doxorubicin (PLD) in Patients with Refractory Epithelial Ovarian Cancer (EOC)

@inproceedings{Song2012126RB,
  title={126 Relationship Between Complement Factors and CC Chemokines and the Pharmacokinetics (PK) and Pharmacodynamics (PD) of PEGylated Liposomal Doxorubicin (PLD) in Patients with Refractory Epithelial Ovarian Cancer (EOC)},
  author={Gina Song and Sally Falk Moore and Teresa K Tarrant and Marina A Dobrovolskaia and David A. Barrow and Prakash Kumar and Suzanne E. Newman and Victoria L. Bae-Jump and Paola A. Gehrig and William C. Zamboni},
  year={2012}
}